These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1159014)

  • 21. Radioreceptor assay and high-performance liquid chromatography yield similar results for serum thioridazine and its major metabolites.
    Rao ML; Brown WA; Wagner R
    Ther Drug Monit; 1988; 10(2):184-7. PubMed ID: 3381236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients.
    Dorado P; Berecz R; Peñas-Lledó EM; de la Rubia A; Llerena A
    Eur J Clin Pharmacol; 2007 May; 63(5):527-8. PubMed ID: 17345072
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of a metabolite of thioridazine and mesoridazine from human plasma.
    Gruenke LD; Craig JC
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):221-5. PubMed ID: 1162173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-column oxidative derivatization for the liquid chromatographic determination of phenothiazines.
    Diehl G; Karst U
    J Chromatogr A; 2000 Aug; 890(2):281-7. PubMed ID: 11009031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
    Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
    Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous assay of thioridazine and its major metabolites in plasma at single dosage levels with a novel report of two ring sulfoxides of thioridazine.
    Wells CE; Juenge EC; Furman WB
    J Pharm Sci; 1983 Jun; 72(6):622-5. PubMed ID: 6875822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenolic metabolites of thioridazine in man.
    Papadopoulos AS; Crammer JL; Cowan DA
    Xenobiotica; 1985 Apr; 15(4):309-16. PubMed ID: 4024665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partitioning of thioridazine and mesoridazine in human blood fractions.
    Dinovo EC; Pollak H; Gottschalk LA
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):143-6. PubMed ID: 6748818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a radioimmunoassay procedure for mesoridazine and its comparison with a high-performance liquid chromatographic method.
    Chakraborty BS; Hawes EM; Midha KK
    Ther Drug Monit; 1987 Dec; 9(4):464-71. PubMed ID: 3424415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum.
    Niedzwiecki DM; Cubeddu LX; Mailman RB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):117-25. PubMed ID: 2746491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, isolation, and characterization of two stereoisomeric ring sulfoxides of thioridazine.
    Juenge EC; Wells CE; Green DE; Forrest IS; Shoolery JN
    J Pharm Sci; 1983 Jun; 72(6):617-21. PubMed ID: 6875821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thioridazine and its metabolites in post mortem blood, including two stereoisomeric ring sulfoxides.
    Poklis A; Wells CE; Juenge EC
    J Anal Toxicol; 1982; 6(5):250-2. PubMed ID: 7176556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on thioridazine and mesoridazine metabolism. II. In vivo metabolism of tritiated drugs in rhesus monkeys.
    Forrest IS; Green DE; Blum A; Serra MT; Loeffler KO
    Commun Psychopharmacol; 1979; 3(5):323-7. PubMed ID: 121276
    [No Abstract]   [Full Text] [Related]  

  • 34. GLC analysis of thioridazine, mesoridazine, and their metabolites.
    Dinovo EC; Gottschalk LA; Nandi BR; Geddes PG
    J Pharm Sci; 1976 May; 65(5):667-9. PubMed ID: 932933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albumin binding of thioridazine and some of its metabolites.
    Vandeheeren FA; Belpaire FM
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):86-91. PubMed ID: 1171660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine.
    Niedzwiecki DM; Cubeddu LX; Mailman RB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):126-33. PubMed ID: 2746492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical characterization of decomposition products of drugs. Part 5: Products of autoxidation and photo-oxidation of thioridazine hydrochloride.
    Pawelczyk E; Marciniec B
    Pharmazie; 1974 Sep; 29(9):585-5. PubMed ID: 4421012
    [No Abstract]   [Full Text] [Related]  

  • 38. Relevance of CYP2D6 -1584C>G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients.
    Dorado P; Peñas-LLedó EM; de la Rubia A; LLerena A
    Pharmacogenomics; 2009 Jul; 10(7):1083-9. PubMed ID: 19604081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artifacts in the analysis of thioridazine and other neuroleptics.
    Eap CB; Koeb L; Baumann P
    J Pharm Biomed Anal; 1993 Jun; 11(6):451-7. PubMed ID: 8104489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.
    Berecz R; de la Rubia A; Dorado P; Fernández-Salguero P; Dahl ML; LLerena A
    Eur J Clin Pharmacol; 2003 May; 59(1):45-50. PubMed ID: 12682803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.